Next, we transplanted mice that had been previously sublethally irradiated (1 × 5 Gy) with 3 × 106 hCD19+ B-ALL cells and administered CAR T cells targeting human CD19 or control antigen (EGFRvIII) 3 days later. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.